FEMY.US Femasys Inc

Healthcare Health Care Equipment & Supplies USA Stocks
1.42 USD
Close of Nov 14, 2026
1.26 20.80
Market cap
USD 11.9M
P/E
-
P/B
2.91x
ROE
-42.9%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is FEMY.US undervalued?

Graham number

The Graham number of Femasys Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Femasys Inc fundamental analysis

No fundamental analysis for Femasys Inc yet.

Femasys Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Femasys Inc

Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and…

Full company profile